Physician

Verena Clarissa Samara, M.D.

According to 2025 Medicare claims, Verena Samara, M.D. (NPI: 1376886846) practices neurology in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is CARSON TAHOE PHYSICIAN CLINICS (NPI: 1023265717; TIN: 02-0566741) and primary practice location at 89703-4648. Samara is affiliated with the Silver State ACO LLC (ACO ID: A2251), participating under the MSSP model.

Samara's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 288 traditional Medicare patients, billed 5,190 HCPCS/CPT codes, and received $114,507 in Medicare payments. The top billing code was 95911 (Nerve conduction, 9-10 studies). Part D data shows 622 prescription claims across 173 beneficiaries totaling $556,913 in drug costs, led by Botox (Onabotulinumtoxina). Open Payments data shows 149 records totaling $8,639. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $17,783 and ending at $114,507. Concurrently, Part D prescription costs have risen steadily, from $2,729 to $556,913. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$57K$115K2018 Medicare payment: $17,783 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $51,641 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $81,604 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $88,643 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $51,042 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $58,164 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $114,507 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201856968$17,783
20191414,367$51,641
20202176,239$81,604
20212255,049$88,643
20221712,398$51,042
20232421,615$58,164
20242885,190$114,507

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$279K$558K2015 Drug cost: $2,729 (USD; Tot_Drug_Cst)2016 Drug cost: $1,578 (USD; Tot_Drug_Cst)2017 Drug cost: $7,797 (USD; Tot_Drug_Cst)2018 Drug cost: $71,539 (USD; Tot_Drug_Cst)2019 Drug cost: $327,398 (USD; Tot_Drug_Cst)2020 Drug cost: $406,645 (USD; Tot_Drug_Cst)2021 Drug cost: $557,772 (USD; Tot_Drug_Cst)2022 Drug cost: $289,656 (USD; Tot_Drug_Cst)2023 Drug cost: $553,701 (USD; Tot_Drug_Cst)2024 Drug cost: $556,913 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151665$2,729
20161260$1,578
20171162$7,797
20182661$71,539
2019113740$327,398
2020169974$406,645
20212121,404$557,772
20222261,140$289,656
20232131,255$553,701
2024173622$556,913

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95911Nerve conduction, 9-10 studies7172$158
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more83115$132
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more74103$95
95886Needle measurement of electrical activity in arm or leg muscles, complete study147280$75
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5566$66

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BotoxOnabotulinumtoxina312,604$38,604
RytaryCarbidopa/Levodopa13627$13,863
Carbidopa-LevodopaCarbidopa/Levodopa754,914$3,303
Mycophenolate MofetilMycophenolate Mofetil141,065$2,727
PrimidonePrimidone231,202$1,713

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.149$8,639UCB, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Verena Clarissa Samara, M.D.?

Tedicare shows public-source Medicare data for Verena Clarissa Samara, M.D. (NPI 1376886846), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Verena Clarissa Samara, M.D. have ACO affiliation data?

Verena Clarissa Samara, M.D. is shown with ACO affiliation data for Silver State ACO LLC (MSSP, ACO ID A2251).

What billing organization is linked to Verena Clarissa Samara, M.D.?

Verena Clarissa Samara, M.D. is linked to CARSON TAHOE PHYSICIAN CLINICS (billing NPI 1023265717) in the available physician profile data.

Does Verena Clarissa Samara, M.D. have Open Payments data?

Verena Clarissa Samara, M.D. has 149 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.